Here are four things to know:
1. The Safety Using NUsurface, or SUN, trial will enroll approximately 120 patients with persistent knee pain.
2. It will include up to 20 sites nationwide.
3. NUsurface is meniscus replacement implant for patients with injured or deteriorating meniscus cartilages.
4. Active Implants first clinical trial for NUsurface, the VENUS Study, has been underway at 10 sites in the United States since January 2015.
More articles on devices:
All MACs to cover Osiris Therapeutics’ Grafix for wound care: 3 points
Bone Therapeutics, Kasios extend collaboration for spinal fusion product: 3 takeaways
Global outsourced orthopedic manufacturing market to reach $2B+ by 2020: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
